ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,066.00
      -0.07%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      66,918.21
      -0.24%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Aventis New Ads (AVE)

      7. Aventis New Ads (AVE) News

      AVE

      Aventis (AVE)

      Aventis New Ads
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:AVE
      DateTimeSourceHeadlineSymbolCompany
      3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
      10/15/20045:03PMPR Newswire (US)Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series ANYSE:AVEAventis New Ads
      10/04/20043:44PMPR Newswire (US)Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care ProvidersNYSE:AVEAventis New Ads
      09/22/20045:23PMPR Newswire (US)Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal DiseaseNYSE:AVEAventis New Ads
      09/21/20049:30AMPR Newswire (US)Aventis Named to List of Top 100 Companies for Working MothersNYSE:AVE
      09/16/20043:00AMPR Newswire (US)The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual IdentityNYSE:AVE
      09/14/20049:30AMPR Newswire (US)Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory DiseaseNYSE:AVEAventis New Ads
      08/19/20049:00AMPR Newswire (US)FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast CancerNYSE:AVEAventis New Ads
      08/11/200411:39AMPR Newswire (US)Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in AdoleNYSE:AVEAventis New Ads
      08/05/20048:02PMPR Newswire (US)Ventiv Health Announces Sales and Marketing Agreement with AventisNYSE:AVEAventis New Ads
      08/03/20042:58PMPR Newswire (US)FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)NYSE:AVEAventis New Ads
      07/28/20043:31PMPR Newswire (US)Aventis Reports Second-Quarter and First-Half Results for 2004NYSE:AVEAventis New Ads
      07/27/200411:29AMPR Newswire (US)Aventis to Move Forward With Reissuance Process for Contested Lovenox PatentNYSE:AVE
      07/07/20049:00AMPR Newswire (US)New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary SyndromesNYSE:AVE
      06/23/200410:50AMPR Newswire (US)Sanofi-Synthelabo's Offer for Aventis Expiration Date of OffersNYSE:AVE
      06/14/200411:43AMPR Newswire (US)Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis DividendNYSE:AVE
      06/07/20041:00PMPR Newswire (US)Two Landmark Studies Show That Taxotere(R) Significantly Improves Survival in Men With Prostate CancerNYSE:AVEAventis New Ads
      06/05/200410:00AMPR Newswire (US)Investigators Report Taxotere(R) Offers Significant Survival Benefits for Head and Neck Cancer PatientsNYSE:AVEAventis New Ads
      06/01/20043:40PMPR Newswire (US)Sanofi-Synthelabo's Offer for Aventis Expiration Date of OffersNYSE:AVE
      05/28/20041:00PMPR Newswire (US)Genta and Aventis Announce Termination of Genasense(TM) Expanded Access Program in MelanomaNYSE:AVEAventis New Ads
      05/27/20043:00AMPR Newswire (US)Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine AgreementNYSE:AVE
      05/26/200411:05AMPR Newswire (US)Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004NYSE:AVE
      05/26/20049:00AMPR Newswire (US)Two Landmark Studies of Taxotere(R) in Prostate Cancer Highlighted in American Society of Clinical Oncology Plenary SessionNYSE:AVEAventis New Ads
      05/23/20041:15PMPR Newswire (US)Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma PatientsNYSE:AVE
      05/23/20041:15PMPR Newswire (US)Surveillance Study Finds Newly-Approved Antibiotic KETEK(R) (telithromycin) Tablets 99% Effective In Vitro Against StreptococcusNYSE:AVE
      05/19/20043:39PMPR Newswire (US)Aventis Receives FDA Approval for Taxotere(R) in Prostate CancerNYSE:AVEAventis New Ads
      05/18/20049:01AMPR Newswire (US)Aventis Receives Priority Review Designation for the Registrational Application to Support the Use of Taxotere(R) in Women withNYSE:AVE
      05/05/200411:12AMPR Newswire (US)Sanofi-Synthelabo's Offer for AventisNYSE:AVE
      05/03/20043:52PMPR Newswire (US)FDA Advisory Committee Reviews Genasense(TM) for Use in Advanced MelanomaNYSE:AVEAventis New Ads
      04/30/20043:55PMPR Newswire (US)Aventis Pasteur Statement on New Influenza Immunization Recommendations for Infants, Young Children and Their Close ContactsNYSE:AVE
       Showing the most relevant articles for your search:NYSE:AVE